XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. 1990

M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
First Department of Medicine, University of Helsinki, Finland.

Fresh blood samples were collected from 103 North Karelians who had in 1981-84 participated in dietary intervention studies and analysis of the XbaI restriction fragment length polymorphism (RFLP) of apolipoprotein B (apoB) was carried out. Reanalysis of the original plasma lipid and apolipoprotein data indicated that while baseline concentrations did not differ significantly between genotypes, the response to a low-fat, low-cholesterol diet was influenced by apoB XbaI genotype: reductions in total and low density lipoprotein (LDL) cholesterol, apoB and high density lipoprotein (HDL) cholesterol were greater in subjects homo- or heterozygous for the presence of the XbaI cutting site (X1X2 or X2X2 genotype, designated X2+) as compared to those lacking the cutting site (X1X1 genotype, designated X2-). The corresponding average reductions induced by dietary intervention in X2+ and X2- subjects were: for total cholesterol 1.30 and 0.99 mmol/l (p = 0.036), for LDL cholesterol 1.04 and 0.78 mmol/l (p = 0.049), for apoB 18.3 and 8.1 mg/100 ml (p = 0.012) and for HDL cholesterol 0.26 and 0.17 mmol/l (p = 0.008).

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands

Related Publications

M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
August 2000, European journal of clinical investigation,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
May 1993, Clinical genetics,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
February 2004, Human genetics,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
January 2013, Indian journal of human genetics,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
January 2007, Annales de biologie clinique,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
May 2001, Current atherosclerosis reports,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
February 1991, Metabolism: clinical and experimental,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
August 2004, Prostaglandins, leukotrienes, and essential fatty acids,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
November 1991, Journal of internal medicine,
M J Tikkanen, and C F Xu, and T Hämäläinen, and P Talmud, and S Sarna, and J K Huttunen, and P Pietinen, and S Humphries
December 1995, Atherosclerosis,
Copied contents to your clipboard!